About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 4NCT01861041

Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.

Spinal anesthesia, is used during the transuretheral resection of the prostate.Low dose hyperbaric local anesthetics have been used to enhance the resolution of the spinal block. We compared the effic...

Lead sponsor: Diskapi Yildirim Beyazit Education and Research Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Diskapi Yildirim Beyazit Education and Research Hospital

Patients undergoing TURP were randomly allocated into two groups. * Group I: Received fentanyl 20 µgr (0.4ml),heavy bupivacaine 0.5% (1.5 ml)and normal saline % 0.9 NaCl ( 1.1ml) * Group II: Received fentanyl 20 µgr (0.4 ml), plain bupivacaine 0.5%(1.5 ml) normal saline 0.9% NaCl (1.1 mL) in total bupivacaine 0.25% (3ml) intrathecally. Onset and duration of the sensory block, the degree of the motor block, side - effects and perioperative analgesic requirement assesed.

Age

50 - 85 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•50-85 years ASA 1-4 BENİGN PROSTAT HYPERPLASİ

Exclusion Criteria

•Allergy of study drugs
•Morbid obesity
•Spinal anesthesia contrindications
•Bleeding dyscrasias

Related studies

Active Not RecruitingNA

En-bloc With Early Apical Release Versus Lobe-by-lobe LASER Enucleation of the Prostate

NCT07014969 · Benign Prostate Hyperplasia, Bladder Outlet Obstruction

COMPLETEDPhase 4

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)

NCT01747577 · Overactive Bladder, Benign Prostate Hyperplasia, and more

Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia

NCT06520267 · Bacteriuria in Symptomatic Benign Prostate Hyperplasia, Antibiotic Susceptibility in Symptomatic Benign Prostate Hyperplasia, and more

Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

NCT02822924 · Benign Prostate Hyperplasia

COMPLETEDPhase 1

Safety and Pharmacokinetic Characteristics of DKF-313

NCT02352311 · Benign Prostate Hyperplasia, Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 23, 2013Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment52

Start dateMay 2013

Last updatedMay 23, 2013

Condition

Benign Prostate Hyperplasia

Locations shown

Diskapi Yildirim Beyazit Education and Research Hospital

Ankara

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions